Get started
Author

K.Y. Westerhout

Observed names: K Westerhout, KY Westerhout, Kirsten Westerhout, Kirsten Y Westerhout, Kirsten Y. Westerhout
Observed institution: Pharmerit (Netherlands)
OpenAlex ID: A5110180262
Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature
2015 · Cathelijne J.M. Alleman, Kirsten Y. Westerhout, et al. · Diabetes Research and Clinical Practice · 235
Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany
2012 · K.Y. Westerhout, B.G. Verheggen, et al. · Journal of Medical Economics · 44
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass‐allergic rhinoconjunctivitis in Germany
2015 · Bram G Verheggen, Kirsten Y Westerhout, et al. · Clinical and Translational Allergy · 37
A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service
2015 · Kirsten Westerhout, Maarten Treur, et al. · Journal of Medical Economics · 19
PDF
Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan
2015 · Hiroyo Kuwabara, Kirsten Westerhout, et al. · Journal of Medical Economics · 14
PDF
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service
2017 · Kirsten Westerhout, Walter Bouwmeester, et al. · ClinicoEconomics and Outcomes Research · 3
PDF
Impact of Allergen Immunotherapy on Symptom-Free Days and Health Care Costs in Patients With Grass Pollen-Induced Allergic Rhinitis in Germany
2014 · M. Najib, K.Y. Westerhout, et al. · Value in Health · 3
PDF
Cost-Effectiveness Analysis of Simeprevir and Sofosbuvir Combination Therapy for the Treatment of Genotype 1 Hcv Patients in the Dominican Republic
2015 · K Pantiri, KY Westerhout, et al. · Value in Health · 2
PDF
Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)
2014 · K.Y. Westerhout, M. Treur, et al. · Value in Health · 2
P15 Cost effectiveness of mepolizumab for severe eosinophilic asthma from the uk perspective
2017 · S Doyle, K Westerhout, et al. · Thorax · 1
PDF
Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the treatment of Chronic Genotype 1 Hepatitis C in Colombia
2015 · JG Ariza, A Taborda, et al. · Value in Health · 1
PDF
PRS11 Budget Impact Analysis of Immunotherapy in Patients with Birch Allergic Rhinitis
2011 · K.Y. Westerhout, B.G. Verheggen, et al. · Value in Health · 1
PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis
2011 · K.Y. Westerhout, B.G. Verheggen, et al. · Value in Health · 1
Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients
2015 · KY Westerhout, W Bouwmeester, et al. · Value in Health
Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico
2015 · M Heibeck, KY Westerhout, et al. · Value in Health
Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In Russia
2014 · E. Pyadushkina, M. Avxentyeva, et al. · Value in Health
Cost-Effectiveness Analysis of Allergen Immunotherapy in Patients With Grass Pollen-Induced Allergic Rhinitis in Spain
2014 · A. Valero, K.Y. Westerhout, et al. · Value in Health
Impact of Allergen Immunotherapy on Quality of Life and Health Care Costs in Adults and Children With Grass Pollen-Induced Allergic Rhinitis in Germany
2014 · M. Najib, K.Y. Westerhout, et al. · Value in Health
PDF
Effect of Antiviral Treatment Rates on the Predicted Future Burden of Genotype-1 Chronic Hepatitis C in the United Kingdom
2013 · K.Y. Westerhout, M. Treur, et al. · Value in Health
Economic Burden of Patients with Painful Diabetic Neuropathy in Europe: A Systematic Literature Review
2013 · C.J.M. Alleman, K.Y. Westerhout, et al. · Value in Health
PDF
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis
2011 · K.Y. Westerhout, B.G. Verheggen, et al. · Value in Health
PDF
Works count: 21
Citation count: 363
H-index: 5
I10-index: 5
Year
Topic
Type